Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Neuro-Oncology
-
-
Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
-
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
-
Sharing News from the Alliance: September Media Mentions
The media relations efforts from Alliance staff and researchers are designed to alert the public about the vital work happening across our network. When we share stories about clinical trial results, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible. See where the Alliance was mentioned September 2026 in…
-
Alliance Trial Finds Fractionated Radiosurgery Reduces Cancer Recurrence After Surgery for Large Brain Metastases
Presented at ASTRO plenary session, Phase III trial results show three to five radiation treatments improved control at the surgical site compared with a single treatment Delivering focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced the risk of cancer returning at the surgical site compared with delivering…
-
Sharing News from the Alliance: August Media Mentions
Our media relations efforts are designed to inform the public about the vital work taking place across our clinical trials network. By sharing stories about clinical trial results, scientific milestones, and investigator achievements, we highlight the real-world progress made possible through the collective efforts of researchers, trial participants, and the broader cancer community. More than…
-
Alliance Clinical Trials Recently Activated
The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials aim to improve outcomes, reduce side effects, and deliver more…
-
Honoring Leadership and Celebrating New Horizons
The Alliance for Clinical Trials in Oncology thrives on the dedication, vision, and expertise of its leadership team. We express our deep gratitude to the outgoing committee chairs whose years of tireless service have fundamentally shaped our research portfolio, advanced clinical trials, and mentored the next generation of investigators while profoundly impacting the lives of…
-
Recently Activated Alliance Trials
The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials aim to improve outcomes, reduce side effects, and deliver more…
-
Recently Activated Alliance Clinical Trials
The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new drug combinations for rare and aggressive cancers to evaluating digital health tools that improve access to genetic services, these trials aim to improve outcomes, reduce…